MC
CLX icon

Maplelane Capital’s Clorox CLX Stock Holding History

Maplelane Capital’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1
Closed – – 142
2017
Q4 		$0 Buy
+1
New +$136 ﹤0.01% 129

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
VAM
ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Maplelane Capital's CLX Position: Q1 2018 in Review

Maplelane Capital sold out of Clorox (CLX) in Q1 2018, closing a stake of 1 share.

Maplelane Capital first reported a position in CLX in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 913 funds tracked by Wall St. Rank hold CLX as of Q1 2018.

  • Maplelane Capital reported no remaining Clorox position as of Q1 2018 after selling out during the quarter.
  • Maplelane Capital sold 1 Clorox share in Q1 2018.
  • Maplelane Capital first reported a position in Clorox in Q4 2017 and held it in 1 quarter.
  • Maplelane Capital's Clorox position peaked at $0 in Q4 2017.
  • 913 funds tracked by Wall St. Rank held Clorox as of Q1 2018.

Based on Maplelane Capital's 13F filing for Q1 2018, filed 15 May 2018.